Relias Media - Continuing Medical Education Publishing

The trusted source for

healthcare information and

CONTINUING EDUCATION.

  • Sign In
  • Sign Out
  • MyAHC
    • Home
      • Home
      • Newsletters
      • Blogs
      • Archives
      • CME/CE Map
      • Shop
    • Emergency
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • Hospital
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • Clinical
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • All Access
      • Subscribe Now
      • My Subscription
    • My Account
      • My Subscriptions
      • My Content
      • My Orders
      • My CME/CE
      • My Transcript
    Home » Blogs » ED Push » Deciding Between Oral Therapy and IV Antibiotics in Skin Infections

    ED Push
    ED Push RSS FeedRSS

    edpush-webheader-rm

    Free Monthly News from the Award Winning Publisher of:

    • Emergency Medicine Reports
    • Trauma Reports
    • Critical Care Alert
    • ED Management
    • ED Legal Letter
    • Pediatric Emergency Medicine Reports
    • EM Reports' Study Guide 2018
    • STROKE: The Cutting Edge: 2017
    • Pediatric Trauma 2018
    • STEMI Watch 2018
     

     

    Deciding Between Oral Therapy and IV Antibiotics in Skin Infections

    August 22, 2018
    No Comments
    Reprints
    Facebook Twitter Linkedin Share Share
    By Brenda Mooney

    Is it better for patients presenting to the ED with nonpurulent skin and soft tissue infections (SSTI) to receive IV antibiotics, or will oral therapy suffice? Because guideline recommendations are unclear, researchers sought more information.

    Investigators conducted a health records review of 500 adults with nonpurulent SSTIs treated at two tertiary care EDs. The goal was to determine how often oral antibiotic treatment failed, defined as either/or hospitalization, change in class of oral antibiotic, or switch to IV therapy after a minimum of 48 hours of oral therapy due to worsening infection.

    Of 288 patients who had received a minimum of 48 hours of oral antibiotics, treatment failure occurred in 85 patients. Independently associated with oral antibiotic treatment failure were tachypnea at triage, chronic ulcers, history of methicillin-resistant Staphylococcus aureus (MRSA) colonization or infection, and cellulitis in the past 12 months.

    The study authors recommended emergency clinicians consider these four factors when crafting treatment and management strategies.

     

    Post a comment to this article

    Report Abusive Comment

    www.reliasmedia.com

    ED Push

    View PDF
    ED Push - Sept 2018 Issue
    September 1, 2018

    Table Of Contents

    High-sensitivity Test for Cardiac Troponin Safe, Effective for ED Use

    What’s the Root of ED Medical Errors?

    Deciding Between Oral Therapy and IV Antibiotics in Skin Infections

    Investigators Explore Evolving Causes of Anaphylaxis

    Shop Now: Search Products

    • Subscription Publications
    • Books & Study Guides
    • Webinars
    • Group & Site
      Licenses
    • State CME/CE
      Requirements

    Webinars And Events

    View All Events
    • Home
      • Home
      • Newsletters
      • Blogs
      • Archives
      • CME/CE Map
      • Shop
    • Emergency
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • Hospital
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • Clinical
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • All Access
      • Subscribe Now
      • My Subscription
    • My Account
      • My Subscriptions
      • My Content
      • My Orders
      • My CME/CE
      • My Transcript
    • Help
    • Search
    • About Us
    • Sign In
    • Register
    Relias Media - Continuing Medical Education Publishing

    The trusted source for

    healthcare information and

    CONTINUING EDUCATION.

    Customer Service

    customerservice@reliasmedia.com

    U.S. and Canada: 1-800-688-2421

    International +1-404-262-5476

    Accounts Receivable

    1-800-370-9210
    ReliasMedia_AR@reliasmedia.com

    Mailing Address

    • 1010 Sync St., Suite 100
      Morrisville, NC 27560-5468
      USA

    © 2021 Relias. All rights reserved.

    Do Not Sell My Personal Information  Privacy Policy  Terms of Use  Contact Us  Reprints  Group Sales

    For DSR inquiries or complaints, please reach out to Wes Vaux, Data Privacy Officer, DPO@relias.com

    Design, CMS, Hosting & Web Development :: ePublishing